Dow Down1.10% Nasdaq Down1.82%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
8.02 Down 0.62(7.18%) 4:00PM EST
|After Hours : 8.02 Up 0.00 (0.02%) 4:59PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
Total Revenue 50,157   33,879   32,727  
Cost of Revenue1,583   -  129  
Gross Profit 48,574   33,879   32,598  
Operating Expenses
Research Development19,230  28,502  45,764  
Selling General and Administrative84,644  25,082  14,517  
Non Recurring -   -   -  
Others2,254  1,495  1,495  
Total Operating Expenses -   -   -  
Operating Income or Loss 20,062   (21,200) (29,178)
Income from Continuing Operations
Total Other Income/Expenses Net77,740  145  561  
Earnings Before Interest And Taxes97,802  (21,055)(28,617)
Interest Expense -   -   -  
Income Before Tax97,802  (21,055)(28,617)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops97,802  (21,055)(28,617)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 20,186   (21,055) (28,617)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 20,186   (21,055) (28,617)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.